Onco GS Blood is a non-invasive liquid biopsy test that analyzes circulating tumor DNA (ctDNA) from a blood sample to detect actionable genetic mutations in lung, colorectal, ovarian, and stomach cancers. This test supports personalized cancer treatment by guiding targeted therapy selection, monitoring disease progression, and reducing the need for invasive tissue biopsies.
14 days upon receipt of sample in lab.